RhoA Inhibitor Treatment At Acute Phase of Spinal Cord Injury May Induce Neurite Outgrowth and Synaptogenesis

The therapeutic use of RhoA inhibitors (RhoAi) has been experimentally tested in spinal cord injury (SCI). In order to decipher the underlying molecular mechanisms involved in such a process, an in vitro neuroproteomic-systems biology platform was developed in which the pan-proteomic profile of the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Cell Proteomics
Autori principali: Devaux, Stephanie, Cizkova, Dasa, Mallah, Khalil, Karnoub, Melodie Anne, Laouby, Zahra, Kobeissy, Firas, Blasko, Juraj, Nataf, Serge, Pays, Laurent, Mériaux, Céline, Fournier, Isabelle, Salzet, Michel
Natura: Artigo
Lingua:Inglês
Pubblicazione: The American Society for Biochemistry and Molecular Biology 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546194/
https://ncbi.nlm.nih.gov/pubmed/28659490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M116.064881
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi